EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis

Fangming Dong, Linlin Qu, Zhiguang Duan, Ying He, Xiaoxuan Ma, Daidi Fan

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Fangming Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi'an, Shaanx…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Research and Development Projects of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High expression of histone deacetylase 2 (HDAC2) is recognized as a marker of invasive breast cancer (BC). HDAC2 is not only responsible for enhancing tumor cell growth, development, and anti-apoptosis, but also plays a significant role in regulating PD-L1 on the surface of tumor cells. Continuous expression of PD-L1 allows tumor cells to escape immune surveillance. There is not much research on how HDAC2 affects the immune system in breast cancer. Ginsenoside Rh4 (Rh4) is a major rare saponin in heat-treated ginseng, which is widely applied in treating and preventing various diseases because of its potent medicinal value and stable safety. However, it is unclear how Rh4 affects the tumor immune microenvironment in breast cancer. Therefore, this paper aims to investigate the effect of Rh4 on HDAC2 in breast cancer, specifically the effect of HDAC2 on apoptosis and the immune microenvironment to inhibit breast cancer growth. According to our study, ginsenoside Rh4 has been shown to significantly suppress breast cancer cell proliferation without any adverse effects. The molecular docking results of Rh4 and HDAC2 indicate a binding energy of -6.06 kcal/mol, suggesting the potential of Rh4 as a targeting modulator of HDAC2. Mechanistically, Rh4 induces apoptosis of breast cancer cells by the HDAC2-mediated caspase pathway and inhibits the HDAC2-mediated JAK/STAT pathway to regulate the immune microenvironment, which inhibits breast cancer growth. Specifically, Rh4 was shown for the first time to blockade immune checkpoints (PD-1/PD-L1) and increase levels of T-lymphocytes in the tumor. In a word, our study establishes a theoretical framework for applying Rh4 as an immune checkpoint inhibitor as part of breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleB7-H1 AntigenHistone Deacetylase 2Janus KinasesMolecular Docking SimulationSignal TransductionSTAT Transcription FactorsCell Line, TumorTumor MicroenvironmentGinsenosides

Stichwörter der Autor:innen

ApoptosisCD8+ T cellGinsenoside Rh4HDAC2PD-L1Tumor immune microenvironment

Substanzen

B7-H1 AntigenHistone Deacetylase 2Janus KinasesSTAT Transcription Factorsginsenoside Rh4Ginsenosides

Autor:innen und Institutionen

  • Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi'an, Shaanxi 710069, China; Shaanxi R&D Center of Biomaterials and Fermentation E…
  • Shaanxi Giant Biotechnology Co., LTD, No. 20, Zone C, Venture R&D Park, No. 69, Jinye Road, High-tech Zone, Xi'an, Shaanxi 710076, China.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Key Research and Development Projects of Shaanxi Province

Zitieren

APA

Dong, F., Qu, L., Duan, Z., He, Y., Ma, X., & Fan, D. (2023). Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106537

Vancouver

Dong F, Qu L, Duan Z, He Y, Ma X, Fan D. Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106537

BibTeX
@article{Dong2023,
  author = {Dong, Fangming and Qu, Linlin and Duan, Zhiguang and He, Ying and Ma, Xiaoxuan and Fan, Daidi},
  title = {Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106537}
}
Kostenlos starten →